Home/Filings/4/0001209191-23-041802
4//SEC Filing

Donovan Michael J. 4

Accession 0001209191-23-041802

CIK 0001811115other

Filed

Jul 6, 8:00 PM ET

Accepted

Jul 7, 4:29 PM ET

Size

5.8 KB

Accession

0001209191-23-041802

Insider Transaction Report

Form 4
Period: 2023-07-06
Donovan Michael J.
Chief Medical Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2023-07-06+85,73185,731 total
    Exp: 2033-07-05Ordinary Shares (85,731 underlying)
Footnotes (2)
  • [F1]The exercise price is 1.025 pounds sterling. The U.S. dollar equivalent of the exercise price is $1.301 using the Bank of England rate as of July 6, 2023 (1.00 pound sterling = $1.269).
  • [F2]One twelfth (1/12th) of the shares subject to the option award shall vest in equal quarterly installments commencing on October 6, 2023, subject to the Reporting Person's continuous service.

Issuer

Renalytix plc

CIK 0001811115

Entity typeother

Related Parties

1
  • filerCIK 0001975278

Filing Metadata

Form type
4
Filed
Jul 6, 8:00 PM ET
Accepted
Jul 7, 4:29 PM ET
Size
5.8 KB